Waystar Holding Corp. Common Stock (WAY) Fair Value & Analysis
Healthcare · US · Market cap $4.3B · ISIN US9467841055
What is Waystar Holding Corp. Common Stock really worth?
Waystar Holding Corp. Common Stock
WAY · US
Below-average quality, and trading another 139% above our fair value of $10.93.
Strengths
Risks
Fair value as of: Sep 3, 2026
From 24 valuation models · updated yesterday
Share price +9.7% over the past month.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
What matters now
- The price sits above even our optimistic bull case ($13.66). The favourable scenario is already priced in.
- Solid but not exceptional quality (49/100) and above fair value, neither a clear bargain nor a standout compounder.
Price vs Fair Value (2 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 3, 2026.
How to read this chart
27‑month range $17.31 – $45.35 · fair‑value band $8.19 – $13.66 · the $26.08 price screens above the $10.93 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 3, 2026.
Analysis
Waystar Holding Corp. Common Stock (WAY) currently trades at $26.08, while our model-based Fair Value estimate is $10.93, implying the stock looks roughly 138.6% overvalued today. The Quality Score stands at 49/100 (below-average quality), in the Healthcare sector. Bull case: the DCF Models group reads highest at a median of $21.29 per share, and 4 of the 24 models we run sit above the $26.08 price. Bear case: the Economic Profit group reads lowest at $4.05, and 20 of the 24 models stay below the price. Evidence for this calculation is medium.
Over the trailing twelve months, Waystar Holding Corp. Common Stock generated revenue of $1.2B at a net margin of 10.9%. Revenue grew 22.4% year over year. It earns a return on equity of 3.6%. Net debt stands at $1.4B. Fundamentals as of Sep 3, 2026
Our scenario range runs from $8.19 (bear case) to $13.66 (bull case); at $26.08, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The last reported earnings sit well below what analysts expect (earnings in transition, for example after write-downs or an earnings dip); whether the stock is cheap or expensive hinges on the expected recovery actually arriving. Read the fair value with that caveat. The share trades about 37% below its 52-week high and 46% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at −68% fair-value upside, at −58%, WAY screens cheaper than that median.
Fair Value models
This estimate rests on fiscal year 2025 figures, and about 8 months have passed since. In that time the company retained roughly $0.4552 per share, which is 4.2 % of the fair value. The fair value deliberately does not add this in: the models value reported figures, not a projection.
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted, family-balanced blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small. Every input is real reported data, nothing guessed.
All 24 models by family
Widest divergence: DCF Models ($21.29) versus Economic Profit ($4.05). Highest evidence: EPV (72).
Notify me when WAY reaches fair value
Put WAY on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.
Set up alert →Free, no payment details. Unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Sep 3, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 50 · Market factors (momentum, volatility) 40
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.
About the company
Waystar Holding Corp. develops a cloud-based software solution for healthcare payments. Its platform offers financial clearance, patient financial care, claim and payer payment management, denials prevention and recovery, clinical integrity and revenue capture, and analytics and reporting solutions. It primarily serves healthcare industry.
Full company description
Waystar Holding Corp. develops a cloud-based software solution for healthcare payments. Its platform offers financial clearance, patient financial care, claim and payer payment management, denials prevention and recovery, clinical integrity and revenue capture, and analytics and reporting solutions. It primarily serves healthcare industry. The company was founded in 2017 and is headquartered in Lehi, Utah.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Waystar Holding Corp. Common Stock reported revenue of $1.1B in FY2025 versus $579M in FY2021, a compound +17.4%/yr. Reported net income was $112M in FY2025.
WAY screens 139% overvalued. Compare with Veeva Systems Inc →
Recent news
External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection.
- Waystar Reaffirms Long-Term Guidance, Lack of KPIs Disappoints, RBC Says
- Waystar Launches New Agentic Solutions Transforming AI Into Action Across the Revenue Cycle
- Waystar Expands Executive Leadership to Accelerate Innovation and Growth
- Waystar (WAY) Upgraded to Buy: What Does It Mean for the Stock?
Peer Group
Health Information Services · 128 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Health Information Services median · lower = cheaper
Strength profile in five axes (Snowflake)
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Health Information Services stocks, each showing price versus our Fair Value estimate (as of Sep 3, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Veeva Systems Inc VEEV | $282.13 | $91.49 | −68% |
| Pro Medicus Limited PME | A$183.71 | A$23.74 | −87% |
| BrightSpring Health Services, Inc BTSG | $59.68 | $21.31 | −64% |
| HealthEquity, Inc HQY | $104.27 | $56.63 | −46% |
| Hinge Health, Inc HNGE | $86.32 | $24.03 | −72% |
| 10x Genomics, Inc TXG | $55.63 | $17.18 | −69% |
| XtalPi Holdings 2228 | HK$8.19 | HK$1.04 | −87% |
| Doximity, Inc DOCS | $24.74 | $25.91 | +5% |
| Privia Health Group PRVA | $21.07 | $5.26 | −75% |
| IKS IKS | ₹1,785 | ₹830.74 | −53% |
Compare Waystar Holding Corp. Common Stock with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Waystar Holding Corp. Common Stock (WAY) overvalued or undervalued?
What is the fair value of WAY?
What is the quality score of WAY?
What is the revenue of Waystar Holding Corp. Common Stock (WAY)?
What is the net profit margin of WAY?
Watch Waystar Holding Corp. Common Stock in the live analysis
One click puts Waystar Holding Corp. Common Stock on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.